 ENCINITAS, Calif., Aug. 29, 2022 GLOBE NEWSWIRE -- Ventyx Biosciences, Inc. Nasdaq: VTYX, Ventyx, a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a range of inflammatory diseases with significant unmet medical need, today announced that Company executives will host investor meetings and provide a company overview during fireside chats at the following upcoming investor conferences: 